Advanced company searchLink opens in new window

CORREVIO (UK) LTD.

Company number 06481819

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
14 Sep 2020 MA Memorandum and Articles of Association
14 Sep 2020 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
16 Jul 2020 AA Accounts for a small company made up to 31 December 2019
17 Jun 2020 TM01 Termination of appointment of Justin Andrew Renz as a director on 27 May 2020
17 Jun 2020 TM01 Termination of appointment of Sheila Mary Grant as a director on 27 May 2020
17 Jun 2020 AP01 Appointment of Mr. Vikram Laxman Kamath as a director on 27 May 2020
17 Jun 2020 AP01 Appointment of Mr. Adeel Ahmad as a director on 27 May 2020
28 May 2020 MR04 Satisfaction of charge 064818190001 in full
27 Jan 2020 CS01 Confirmation statement made on 23 January 2020 with no updates
11 Sep 2019 AA Accounts for a small company made up to 31 December 2018
24 Jul 2019 AD02 Register inspection address has been changed from C/O Mccarthy Tetrault 125 Old Broad Street London EC2N 1AR England to C/O Mccarthy Tetrault 1 Angel Court 18th Floor London EC2R 7HJ
23 Jul 2019 AD03 Register(s) moved to registered inspection location C/O Mccarthy Tetrault 125 Old Broad Street London EC2N 1AR
27 Mar 2019 RP04CS01 Second filing of Confirmation Statement dated 23/01/2019
27 Mar 2019 CH01 Director's details changed for Ms Sheila Mary Grant on 25 March 2019
06 Mar 2019 PSC02 Notification of Correvio Pharma Corp. as a person with significant control on 15 May 2018
06 Mar 2019 PSC07 Cessation of Cardiome Pharma Corp. as a person with significant control on 15 May 2018
06 Mar 2019 PSC05 Change of details for Correvio Pharma Corp. as a person with significant control on 15 May 2018
31 Jan 2019 CS01 Confirmation statement made on 23 January 2019 with no updates
  • ANNOTATION Clarification a second filed CS01 (statement of capital change and shareholder information change) was registered on 27/03/2019.
28 Jan 2019 PSC05 Change of details for Cardiome Pharma Corp. as a person with significant control on 15 May 2018
05 Jul 2018 AA Accounts for a small company made up to 31 December 2017
24 Jan 2018 CS01 Confirmation statement made on 23 January 2018 with no updates
26 Oct 2017 AP01 Appointment of Ms Sheila Mary Grant as a director on 17 October 2017
26 Oct 2017 TM01 Termination of appointment of David Douglas Mcmasters as a director on 17 October 2017
25 Sep 2017 AA Accounts for a small company made up to 31 December 2016
05 Sep 2017 AP01 Appointment of Mr Justin Andrew Renz as a director on 28 August 2017